PC3I Faculty Roger Kim, MD, MSCE has received a K08 Mentored Clinical Scientist Career Development Award from the National Cancer Institute (NCI), which provides support and mentorship to clinician scientists for research and career development activities. This grant will fund his research aiming to determine the clinical utility, clinical effectiveness, and cost-effectiveness of using a radiomics-based artificial intelligence computer-aided diagnosis (CAD) tool for risk stratification of indeterminate pulmonary nodules. His proposed pragmatic randomized clinical trial has been registered on ClinicalTrials.gov (NCT05968898), with plans to begin enrollment in early 2024.
Roger Kim, MD, MSCE is an Innovation Faculty member at the Penn Center for Cancer Care Innovation, Instructor of Medicine in the Section of Interventional Pulmonology and Thoracic Oncology within the Division of Pulmonary, Allergy and Critical Care at the University of Pennsylvania, and currently the only interventional pulmonologist in the country with an NCI-funded Career Development Award.
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine
Research led by PC3I Faculty Emily Ko showed that implementing telehealth into clinical trials is both safe and feasible.
PC3I Faculty, Fellows, and Staff present 17 abstracts at the 2023 ASCO Quality Care Symposium in Boston, MA.